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Cancer cells are mainly dependent on glycolysis to generate adenosine triphosphate (ATP) and in-
termediates required for cell growth and proliferation. Thus, inhibition of glycolysis might be of thera-
peutic value in antitumor treatment. Our previously studies had found that both 3-bromopyruvate (BP)
and sodium citrate (SCT) can inhibit tumor growth and proliferation in vitro and in vivo. However, the
mechanism involved in the BP and SCT mediated antitumor activity is not entirely clear. In this work, it is
demonstrated that BP inhibits the enzyme hexokinase (HK) activity and SCT suppresses the phospho-
fructokinase (PFK) activity respectively, both the two agents decrease viability, ATP generation and
lactate content in the human gastric cancer cell line MGC-803. These effects are directly correlated with
blockage of glycolysis. Furthermore, BP and SCT can induce the characteristic manifestations of
mitochondria-regulated apoptosis, such as down-regulation of anti-apoptosis proteins Bcl-2 and Survi-
vin, up-regulation of pro-apoptosis protein Bax, activation of caspase-3, as well as leakage of cytochrome
c (Cyt-c). In summary, our results provided evidences that BP and SCT inhibit the MGC-803 cells growth
and proliferation might be correlated with inhibiting glycolysis and promoting mitochondria-regulated
apoptosis.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Gastric cancer is one of the most common carcinomas in the
worldwide and represents high mortality [1]. Despite of the
improvement of treatments (including surgery, chemotherapy and
radiotherapy), there are approximately 700,000 people die of such
cancer each year, which occupies about 10% of all cancer deaths
occurring all over the world [2]. Such cancer represents a dismal
prognosis and low median survival, the 5-year survival of patients
is less than 30% in spite of treatment with surgery [3]. Therefore,
potent treatment of gastric cancer, is a concerning focus of current
research.
Malignant cells are characterized by a high-energy demand incitrate; 5-FU, 5-ﬂuorouracil.
Wang), doctorlife@126.com
Inc. This is an open access article uorder to maintain proliferation and invasion. Base on “Warburg
effect”, the tumor cells preferentially utilize glycolysis for glucose-
dependent ATP generation even in the presence of ample oxygen to
sustain mitochondrial respiration [4]. Compared to normal cells,
glucose uptake by cancer cells can increase by up 10e15-fold [5].
Considering the glycolytic phenotype in most cancer cells, inhibi-
tion of glycolysis may be the valuable and promising way to anti-
cancer in future. Our group has explored the potential potent
agents on anti-glycolysis on tumor growth for many years, in
particular of mesothelioma and gastric carcinoma [6,7]. Interest-
ingly, any inhibition of the glycolysis can, to a large content, slow
down the proliferation of malignant cells and/or induce apoptotic
cells death, which is involved in overcoming resistance of cancers
to conventional radio- and chemotherapy, reported by numerous
observational studies, including ours [6e8].
The alkylating agent 3-Bromopyruvate (BP), analogs to lactate
and pyruvate, is a molecular that plays a key role in energetic
metabolism [9]. Studies with hepatocellular carcinoma(HCC) by the
team of Pedersen demonstrated that BP may block the mitochon-
drial hexokinase (mt-HK), which was found in most cancer cellsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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discovered this compound has the potential anticancer effect [9,10].
Another novel and promising anticancer agent SCT, a safe natural
substance available in citrus fruits, plays a vital role in biological
metabolism. SCT is a precursor for aliphatic acid biosynthesis in
rapidly proliferating cells and a member of the mitochondrial
tricarboxylic acid cycle (also called Krebs cycle) [11]. Moreover, SCT
is an important inhibitor of glycolysis: it inhibits the effect of
phosphofructokinase, which catalyzes the reaction that transforms
fructose-6-phosphate into fructose-1,6-diphosphate [12]. In addi-
tion, numerous reports have conformed that SCT inhibited the
growth of human ovarian carcinoma, leucocythemia andmedullary
thyroid cancer [11,13,14]. Our group previous studies have eluci-
dated that BP and SCT exhibited a potent effect on malignant
pleural mesothelioma and gastric cancer cells SGC-7901 both
in vitro and in vivo [6,7,15,16], we tempt to study whether both the
agents have the similar effect on the more poorly differentiated
adenocarcinoma of human gastric cancer cell lines MGC-803 and
further investigate the probable mechanisms.
In the present study, to explore the effect of BP and SCT on
glycolytic pathway, we detected the content of intracellular ATP
and lactate, the activity of glycolytic key enzymes HK and PFK in
gastric cancer MGC-803 cells after treatment with BP and SCT.
Besides, we also analyzed the expression of apoptosis-related genes
Bcl-2, Bax, Survivin, Caspase-3 and Cyt-c to investigate effect of
these agents on the mitochondria-regulated apoptotic pathway.
2. Materials and methods
2.1. Reagents
PRMI-1640 medium and fetal bovine serum (FBS) were pur-
chased from Gibco (Thermo Fisher Scientiﬁc, Waltham, MA, USA).
BP, SCT and 5-ﬂuorouracil (5-FU) were purchased from Sigma-
Aldrich (St. Louis, MO, USA).
2.2. Cell culture
Gastric cancer cell lines MGC-803 was purchased from Cell Bank
of Chinese Academy of Sciences (Shanghai, China). This cell linewas
cultured in RPMI-1640 medium supplemented with 10% (v/v) fetal
bovine serum and 1% (v/v) penicillin-streptomycin in an incubator
with a humidiﬁed atmosphere of 5% CO2 at 37 C. Exponentially
growing cells were used for experiments. The morphological
change of MGC-803 cells was observed with inverted microscope.
2.3. MTT assay
Cell viability was assessed using MTT assay. Approximately
3  103 cells were seeded into each well of a 96-well culture plate
and incubated for 24 h. Complete medium was used to dilute the
drug to the desired concentrations for (1, 2, 3, 4, 5, 6, 8,10 and 12 mg/
ml) BP and (1.25, 2.5, 5, 10, 15, 20, 30, 40 and 60 mM) SCT, and the
corresponding drug-containing medium was added to each well.
Incubation in a CO2 incubator was allowed for another 24 h and
48 h respectively. 30 ml of MTT solution was added and followed by
incubation for 4 h. Then supernatant aspiration and DMSO addition
(150 ml/well) were done, and the OD valuewas measured at 490 nm
with microplate reader.
2.4. Flow cytometer analysis
MGC-803 cells in the logarithmic growth phase were trypsi-
nized and seeded into culture ﬂasks. The corresponding drug-
containing medium was added (4, 6, 8 mg/ml of BP; 5, 10, 20 mMof SCTand 0.5mMof 5-FU) after cells were attached to the ﬂasks for
24 h respectively, and negative control group was included at the
same time. For cell cycle analysis, after incubation for 24 h, the cells
were harvested and washed twice with PBS, and ﬁxed in cold 70%
ethanol overnight at 4 C. After RNase A (0.2 mg/ml) digestion for
30 min at 37 C, cells were stained with PI (50 mg/ml) for 30 min at
4 C in dark. For apoptosis analysis, cells were collected after
treatment for 24 h and 48 h, and washed twice with cold PBS. Then
the cells were resuspended in 100 ml of binding buffer, PE and 7-
ADD was added respectively and mixed well. The reaction was
performed at room temperature for 30 min in dark. Another 400 ml
0f binding buffer was added after staining. Finally, a ﬂow cytometer
(BD, FACSCalibur) was used to detect the cell cycle repartition and
apoptosis.
2.5. Determination of the content of lactate and ATP and the
activity of glycolytic enzymes
MGC-803 cells were incubated with corresponding drugs (4, 6,
8 mg/ml of BP; 5,10, 20mM of SCT and 0.5 mM of 5-FU) respectively.
For the detection of lactate and the activity of HK and PFK, the in-
cubation was for 24 h and 48 h. And for the detection of ATP con-
tent, the cells were incubated for 4 h and 8 h. After incubation, cells
were collected and washed twice with cold PBS. The content of
lactate and ATP and the activity of HK and PFK were measured with
Assay Kits (Najing jiancheng Bioengineering Institute, Nanjng
China) respectively. And the detection was performed according to
the manufacturer’s instructions.
2.6. Reverse transcriptase-polymerase chain reaction assay
MGC-803 cells were harvested after treatment with corre-
sponding drugs (4, 6, 8 mg/ml of BP; 5, 10, 20 mM of SCT and 0.5 mM
of 5-FU), and negative control groupwas included at the same time.
Total RNA was prepared with an RNeasy kit (Axygen, Union City,
USA) and reverse-transcribed using PrimeScript® RT reagent Kit
(Takara, Japan). The primers of Bcl-2, Bax, Survivin, Cyt-C, Case-
pase-3 and GAPDH were synthesized by Sangong Biotech
(Shanghai, China) (see Table 1). The reactions were conformed by
SYBR Green PCR Master Mix (Roche, USA). Real-time PCR assays
were performed using Applied Biosystems® 7500 Real-Time PCR
Systems (Life technologies, USA) according to the manufacturer’s
instructions. Real-time PCR data were quantiﬁed using the 2△△Ct
method.
2.7. Western blot analysis
MGC-803 cells were incubated with BP, SCT and 5-FU for 24 h
respectively and washed twice with cold PBS after collection, then
lysed in cell lysis reagent. The reaction was performed on ice for
20 min, then the lysate was centrifugated at 4 C 12,000 rpm for
30 min. The supernatant was saved, and the protein concentration
of samples was measured with BCA method. The proteins were
resolved on a 15% SDS-PAGE gel and transferred to a nitrocellulose
membrane. Then the membrane was blocked overnight with 5%
non-ﬂat milk, and the primary antibody (1:200) was added to
incubated overnight at 4 C. After incubation of primary antibody,
the membrane was washed three times for 10 min with PBST, and
then incubated with the secondary antibody (1:4000) for 1 h.
Finally, the gray scale values of the protein bands were determined
by Odyssey software (LI-COR,Lincoln,NE,USA).
2.8. Statistical analysis
All values were presented as means ± standard deviation and
Table 1
Sequence of Bcl-2, Bax, Survivin, Cyt-C, Casepase-3 and GAPDH primers and conditions of PCR ampliﬁcation.
Gene Primer sequence Production length (bp)
Bcl-2 forward:50-GAGGATTGTGGCCTTCTTTG-30 180
reverse:50-GTGCCGGTTCAGGTACTCA-30
Bax forward:50-CCGATTCATCTACCCTGCTG-30 488
reverse:50-TGAGCAATTCCAGAGGCAGT-30
Survivin forward:50- TCAAGGACCACCGCATCTCT-30 398
reverse:50- CAGTGGGGCAGTGGATGAA-30
Cyt-c forward:50-TGTCGGCATTAAGAAGAAGGA-30 562
reverse:50-TAAATCAGGACTGCCCAACA-30
Cspase-3 forward:50-TGTGGCATTGAGACAGAC-30 371
reverse:50-CACTTGCCATACAAACTA-30
GAPDH forward:50- GTCAGCCGCATCTTCTTT -30 387
reverse:50- CGCCCAATACGACCAAAT-30
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was performed to compare the difference between groups under
different conditions, P values less than 0.05 were considered
signiﬁcant.3. Results
3.1. The inhibitory effect of BP and SCT on proliferation of MGC-
803 cells
To evaluate the effect of BP and SCT on cell proliferation, we
investigated the viability of MGC-803 cells after treatment of a
range of concentrations of BP and SCT for 24 h and 48 h respectively
byMTTassay. As showed in Fig.1, the viability of MGC-803 cells wasFig. 1. Morphologic changes of MGC-803 cells treated with BP and SCT and inhibition of t
FU and various concentration of BP and SCT for 48 h, observed photographed with an inverte
of MGC-803 cells in a dose- and time-dependent manner. Mean absorbance detected in thmarkedly decreased after exposure to BP and SCT in a dose- and
time-dependent manner. The IC50 are 5.73 ± 0.75 mg/ml and
10.08 ± 0.87 mM after 48 h of exposure to BP and SCT respectively.
In addition, direct observation of cells morphology with an inverted
microscope revealed that numerous morphological changes
occurred in cells after treatment with BP and SCT. In particular, cell
shrinkage, condensation of cytoplasm and chromosomal conden-
sation in a dose-dependent manner after the treatment of BP and
SCT for 48 h.3.2. Promotion of apoptosis by BP and SCT in MGC-803 cells
The effect of BP and SCT on cell viability in MGC-803 cells were
analyzed by the method of Annexin V-PE and 7-ADD doublehe cell growth of BP and SCT on MGC-803 cells. A: cells were exposed to 0.5 mM of 5-
d microscope (magniﬁcation  200). B: inhibitory effect of BP and SCT on proliferation
e MTT assay after with 4, 6, 8 mg/ml of BP and 5, 10, 20 nM of SCT for 24 h and 48 h.
Fig. 2. The effect of different concentration of BP and SCT on apoptosis and cell cycle progressions of MGC-803 cells. (A, C): After incubated with BP(4, 6, 8 mg/ml), SCT(5, 10,
20 mM) and 5-FU(0.5 mM) for 24 h and 48 h respectively, the percentage of apoptotic cells increased in a dose- and time-dependent manner, 5-FU induced cell apoptosis
remarkably. (B, D): After treatment with BP(4, 6, 8 mg/ml), SCT(5, 10, 20 mM) and 5-FU(0.5 mM), the cell cycle was analyzed with ﬂow cytometry, the cell cycle was dose-
dependently blocked at G2/M phase, and the percentage of cells at G1 phase was decreased signiﬁcantly. The data are presented by mean ± standard deviation (n ¼ 3).
*p < 0.05 vs control group at the same time. #p < 0.05 vs the same group at different time.
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both BP and SCT induced apoptosis in MGC-803 cells in a dose- and
time-dependent manner. However, 5-FU also promoted MGC-
803 cells to apoptosis remarkably.
3.3. BP and SCT caused MGC-803 cells cycle arrest at G2/M phase
The cell cycle plays key roles in cancer cell proliferation. The cell
cycle repartitionwas analyzedwith PI staining. As showed in Fig. 2B
and D, more cells treated with BP and SCT were arrested at G2/M
phase compared with control group, while cell numbers at G1
phase were decreased. The results presented concentration
dependent. Meanwhile, 5-FU had the same effect on the cell cycle
as BP and SCT.
3.4. BP and SCT reduced intracellular ATP level of MGC-803 cells
Intracellular ATP level was considered the key role in growth
and proliferation of malignant tumor cells. To detect intracellular
ATP content, MGC-803 cells were incubated with different con-
centrations of BP and SCT for 4 h and 8 h. As presented in Fig. 3A,
both BP and SCT could prominently suppress the intracellular ATP
generation in a dose- and time-dependent manner. In addition, 5-
FU could also reduce ATP production in MGC-803 cells.
3.5. BP and SCT suppressed lactate production of MGC-803 cells
In order to study whether BP and SCT regulate the glycolyticmetabolism in MGC-803 cells, we measured the generation of
lactate in MGC-803 cells after treatment with BP and SCT for 24 h
and 48 h respectively. As presented in Fig. 3B, the intracellular
lactate production was signiﬁcantly decreased in BP- and SCT-
treated cells comparatively with untreated cells, and the results
displayed dose- and time-dependent. However, no differences
were perceived on the intracellular concentration of lactate be-
tween 5-FU group and control group.
3.6. The effect of BP and SCT on the activity of glycolytic key
enzymes
To investigate the effect of BP and SCT on glycolytic metabolism,
the activity of HK and PFK was taken into account. As showed in
Fig. 3C and D, after incubated with BP for 24 h and 48 h, the activity
of HK was down regulated in a dose- and time-dependent manner.
However, no differences were observed on the HK activity in SCT-
and 5-FU-treated groups compared with control group. In addition,
the PFK activity was concentration- and time-dependently sup-
pressed by SCT. Interestingly, BP and 5-FU had no distinct effect on
the PFK activity in MGC-803 cells.
3.7. The effect of BP and SCT on the mRNA and protein expressions
of apoptosis related genes
To study the effect of BP and SCT on apoptosis regulatory genes,
the relative expression revel of anti-apoptotic Bcl-2 and Survivin,
and pro-apoptotic Bax, caspase-3 and Cyt-c were taken into
Fig. 3. The effect of BP and SCT on ATP generation and glycolytic metabolism in MGC-803 cells. A: MGC-803 cells were exposed to various concentration of BP and SCT for 4 h
and 8 h, intracellular ATP generation was detected with ATT assay. BeD: After treatment with different dose of BP and SCT for 24 h and 48 h, the content of lactate and activity of
glycolysis key enzymes HK and PFK were measured with enzymes combined method. The data are presented by mean ± standard deviation (n ¼ 3). *p < 0.05 vs control group at the
same time. #p < 0.05 vs the same group at different time.
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the expression level of mRNA and proteins of apoptosis related
genes were detected with qPCR and western blot respectively. As
showed in Fig. 4, both BP and SCT statistically decreased the mRNA
and protein expressions of anti-apoptotic Bcl-2 and Survivin,
whereas, increased the mRNA and protein expression level of pro-
apoptotic Bax, caspase-3 and Cyt-c. The regulating effect of BP and
SCT on the apoptosis related genes was in a dose-dependent
manner. Meanwhile, 5-FU had also the same effect on these
apoptosis related genes as BP and SCT.
4. Discussion
Gastric cancer is threatening the health of people around the
world [1,2]. Despite its high mortality and morbidity, the molecular
mechanism of initiation and progression of this disease remains
unknown. In the absence of effective chemotherapy, other anti-
cancer treatments are often doomed to failure. Although adjuvant
chemotherapy and neoadjuvant chemotherapy have been put into
use in clinical practice in recent years, the survival time of patients
has not been prolong signiﬁcantly [17]. Thus, it is necessary to ﬁnd
novel potent agents to conquer gastric tumor. 5-FU is widely used
in clinical as a kind of chemotherapeutics for the treatment of
gastric cancer due to its antitumor activity. In this study, we used 5-
FU as the positive control agent to study the effect of BP and SCT on
the poorly differentiated adenocarcinoma of human gastric cancer
cell lines MGC-803, and investigate the probable molecular
mechanisms of them on anticancer.
Malignant cells use glycolysis as the main source for energy,
meanwhile, a mass of lactate and pyruvate is generated during the
process. However, lactate, the end product of glycolysis, is exported
to the extracellular medium and contributes to the acidiﬁcation of
tumor microenvironment, which favors tumor development, in-
vasion, chemotherapy and radiotherapy resistance, and recurrence
of tumor and suppresses the immune defense of anticancer [18].Furthermore, evidence has indicated that lactate may enter stroma
and cancer cells following oxidative phosphorylation and may in
turn alternatively produce pyruvate as energetic substrate by tu-
mor cells [19]. Besides, the efﬁciency of glycolysis was modulated
by its key enzymes. Hexokinase, the ﬁrst rate-limiting enzyme of
glycolysis, is considered to catalyze the conversion of glucose to
glucose-6-phosphate in the ﬁrst step of glycolytic reaction [20], and
it is reported that inhibition of HK could induce mitochondrial out
membrane permeabilization [21]. Another glycolytic key enzyme,
phosphofructokinase, catalyzes the conversion of fructose-6-
phosphate to fructose-1-6-bisphosphate irreversibly, which is
considered to be the ﬁrst irreversible reaction of glycolytic pathway
[22]. The data in this study has showed that BP and SCT could
prominently suppress the generation of intercellular ATP and
lactate. However, BP remarkably inhibited the activity of HK and
SCT hindered the PFK activity selectively, whichwas in linewith the
evidences studied before [6,9]. The results mentioned above
demonstrated that both BP and SCT could inhibited glycolytic ﬂux
in MGC-803 cells by suppressing the activity of glycolytic key en-
zymes, resulted in ATP depletion and decreasing lactate generation,
which induced insufﬁcient of energy supplement to support cancer
cells mitosis, DND repairation, proliferation and invasion. The acidic
microenvironment, which favors cancer cells resistance to
chemotherapy, was disrupted by decreasing production of lactate.
Additionally, SCT is reported to be a precursor and a booster of fatty
acid synthesis [7,23], when SCT is abundant, fatty acid synthesis is
enhanced and ATP consumption is further increased at the same
time. Ultimately, the intercellular energy is exhausted, cancer cells
end up to apoptosis and/or necrosis.
However, apoptosis is a spontaneous process of programmed
cell death, which can be induced by a variety of physical and
chemical factors, and is precisely regulated by organism. Although
there are three predominant signaling pathways in apoptosis (the
mitochondrion, the death receptor and the endoplasmic reticulum
signaling pathways), the integration and ampliﬁcation of apoptotic
Fig. 4. The effect of BP and SCT on the relative expression revel of the apoptosis related genes in MGC-803 cells. The expression of Bcl-2, Bax, Survivin, caspase-3 and Cyt-c in
MGC-803 cells were determined by western blot (A). BP and SCT down regulated the mRNA and protein expression level of Bcl-2 and Survivin (B,D), up regulated the mRNA and
protein expression level of Bax, Caspase-3 and Cyt-c remarkably in a dose-dependent manner (C,E). The data are presented by mean ± standard deviation (n ¼ 3). *p < 0.05 vs
control group.
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regulated by Bcl-2 family genes [24]. Evidences have veriﬁed that
Bcl-2 protects against multiple signals that lead to cell apoptosis,
and it is associated with the outer mitochondrial membrane, where
is a pivotal part in protecting mitochondrial integrity and function,
whereas Bax induces mitochondrial permeability transition by
antagonizing the function of Bcl-2, results in stimulating mito-
chondria to release apoptosis-related bioactive substances, such as
Cyt-c, which activates caspase-3/caspase-9 and initiates a caspase
signaling cascade and induces apoptosis [25]. However, caspase-3,
one of the most important members of caspase protein family, is
the key executor of cell apoptosis. When activated by the external
apoptosis signals, caspase-3 can induce the apoptosis signaling
pathway by the interaction of many other proteases. Our observa-
tion from ﬂow cytometry presented that BP and SCT can induce
MGC-803 cells to apoptosis signiﬁcantly. Meanwhile, both BP and
SCT prominently downregulated the mRNA and protein expression
of Bcl-2, whereas upregulated the expression of Bax mRNA and
protein, the expression of Cyt-c and caspase-3 was increased at the
same time. The results presented above demonstrated that both BP
and SCT have the potency to induce the downregulation of Bcl-2
and the upregulation of Bax, which destroy the integrity of mito-
chondria and release abundance of Cyt-c to cytoplasm, activate theactivity of caspase-3 and promote MGC-803 cells to mitochondria-
regulated apoptosis ultimately. In addition, survivin was reported
to be the strongest anti-apoptotic factor with the smallest molec-
ular weight and was expressed in a cell-regulated manner in the
G2/M phase of the cell cycle [26], the interaction of survivin with
the mitotic spindle is essential for anti-apoptotic function, it can
also inhibit the activation of downstream effectors of caspase-3
[27]. The results of this study presented that both BP and SCT
could signiﬁcantly suppressed the mRNA and protein expression of
survivin, and arrest cell cycle in G2/M phase, which indicated that
BP and SCT inhibited the expression of survivin and arrested cell
cycle, resulted in cell apoptosis.
In summary, the results of the present study reveal that both BP
and SCT could inhibit growth and proliferation of MGC-803 cells
and block glycolytic pathway and regulated the Bcl-2 family genes
to induce mitochondria-regulated apoptosis. These observations
will add new light in the ﬁeld of developing therapeutic strategies
for gastric cancer in the near future on BP and SCT.Acknowledgements
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